John C. Hiserodt - Concepedia

Author

John C. Hiserodt

Also Known As

G.S. Rose, J C Hiserodt, J. C. HISERODT, J. C. Hiserodt, J. Hiserodt, J.C Hiserodt, J.C. Hiserodt, JOHN C. HISERODT, John C Hiserodt, John C. Hiserodt

126

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

University of California, Irvine UPMC Hillman Cancer Center University of Pittsburgh University of California, Los Angeles University of Brescia

About

John C. Hiserodt is an author at University of California, Irvine specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	46	2.7K
2	Allergy	12	12	901
3	Engineering	7	7	210
4	Biochemistry	3	3	60
5	Natural Sciences	1	1	15

John C. Hiserodt

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. William H. Chambers, Nikola L. Vujanović, Albert B. DeLeo, The Journal of Experimental Medicine AllergyAutoimmune DiseaseTriggering StructureMedicineImmunology	1989	363
NKR-P1, a Signal Transduction Molecule on Natural Killer Cells Roberto Giorda, William A. Rudert, C. Vavassori, Science Molecular ImmunologyNatural Killer CellsSignal Transduction MoleculeMedicineImmunology	1990	241
Lymphokine-activated killer cell activity Ronald B. Herberman, John C. Hiserodt, Nicola L. Vujanovic, Immunology Today AllergyImmunologyLymphatic SystemImmunologic MechanismAutoimmunity	1987	236
Characterization of the cytolytic reaction mechanism of the human natural killer (NK) lymphocyte: resolution into binding, programming, and killer cell-independent steps. John C. Hiserodt, L J Britvan, Stephan R. Targan The Journal of Immunology Cell-independent StepsImmunotoxicologyNk CytolysisLymphocyte DevelopmentImmunology	1982	175
Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells. Nikola L. Vujanović, Ronald B. Herberman, Azzam A. Maghazachi, The Journal of Experimental Medicine ImmunotoxicologyLaboratory ImmunologyLymphocyte DevelopmentImmunologyImmunologic Mechanism	1988	145
NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium James C. Ryan, Eréne C. Niemi, R D Goldfien, The Journal of Immunology	1991	122
A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cells. Robert J. Melder, Theresa L. Whiteside, Nicola L. Vujanovic, PubMed Il2-activated MncImmunologySelective EnrichmentImmune Cell TherapyImmunotherapy	1988	119
Generation and characterization of purified adherent lymphokine-activated killer cells in mice. Y Gunji, Nikola L. Vujanović, John C. Hiserodt, The Journal of Immunology Cell TherapyAdaptive Immune SystemImmunologyNk CellsPathology	1989	102
In vivo treatment with monoclonal antibody 3.2.3 selectively eliminates natural killer cells in rats. Marcel R.M. van den Brink, L Hunt, John C. Hiserodt The Journal of Experimental Medicine ImmunologyNk CellsImmunologic MechanismImmune SystemImmunotherapy	1990	90
Enhanced antimetastatic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic. Roderich E. Schwarz, Nikola L. Vujanović, John C. Hiserodt PubMed Cell TherapyIl-2 TherapyImmunologyImmunologic MechanismImmunotherapy	1989	79

Page 1